Extracellular nucleotides regulate a broad range of cellular responses such as platelet aggregation, vascular tone, cell proliferation, mucociliary clearance, cardiac and skeletal muscle contraction, and neurotransmission (1-4) . The effects of extracellular nucleotides are mediated by two large subfamilies of receptors, the ligand-gated channel P2X receptors (P2X 1-7 ) and the G protein-coupled P2Y receptors (P2Y 1, 2, 4, 6, 11 ) (4 -6). ADP, and less potently ATP, activates the P2Y 1 receptor, while ATP and UTP are the most potent agonists at the P2Y 2 receptor. In addition, ATP selectively activates the P2Y 11 as well as all P2X receptors. UTP is the selective agonist for the P2Y 4 receptor, 1 and UDP acts potently and selectively on the P2Y 6 receptor (7-10). The molecular identification and the wide tissue distribution of these nucleotide target proteins confirm that both adenosine and uridine di-and triphosphates subserve important extracellular signaling roles.
P]orthophosphate. These results illustrate for the first time a constitutive release of ATP and other nucleotides and reveal the existence of a complex extracellular metabolic pathway for released nucleotides. In addition to the existence of an ecto-ATPase activity, our results suggest a major scavenger role of ecto-ATP pyrophosphatase and a transphosphorylating activity of nucleoside diphosphokinase.
Extracellular nucleotides regulate a broad range of cellular responses such as platelet aggregation, vascular tone, cell proliferation, mucociliary clearance, cardiac and skeletal muscle contraction, and neurotransmission (1) (2) (3) (4) . The effects of extracellular nucleotides are mediated by two large subfamilies of receptors, the ligand-gated channel P2X receptors (P2X [1] [2] [3] [4] [5] [6] [7] ) and the G protein-coupled P2Y receptors (P2Y 1, 2, 4, 6, 11 ) (4 -6). ADP, and less potently ATP, activates the P2Y 1 receptor, while ATP and UTP are the most potent agonists at the P2Y 2 receptor. In addition, ATP selectively activates the P2Y 11 as well as all P2X receptors. UTP is the selective agonist for the P2Y 4 receptor, 1 and UDP acts potently and selectively on the P2Y 6 receptor (7-10). The molecular identification and the wide tissue distribution of these nucleotide target proteins confirm that both adenosine and uridine di-and triphosphates subserve important extracellular signaling roles.
ATP is known to be released in a Ca 2ϩ -dependent manner from storage compartments in nerve terminals, chromaffin cells, mast cells, and circulating platelets (1, 4, 11) . Nucleotide release also occurs from non-excitatory tissues, and an autocrine/paracrine function for extracellular adenine nucleotides has been proposed (2, 3, 14 -22) . Recent studies indicate that relatively large amounts of ATP and UTP are released by mechanical stimulation (e.g. shear stress, hypotonic swelling, or stretch) of epithelial and endothelial cells, smooth muscle, glial cells, fibroblasts, and hepatocytes (14 -23) , and these nucleotides in the extracellular medium promote a robust activation of P2 receptors (16, 21, (23) (24) (25) .
Ecto-nucleotidases and other ecto-enzymes metabolize extracellular ATP and UTP (26) . However, the relative functional importance of these different enzymatic activities has not been defined for a given cell type, and little understanding is available of how these enzymes work in concert to produce the final pattern of metabolism of nucleotides. This is an important question given the aforementioned different selectivities of activation of P2Y receptors by both di-and triphosphate adenine and uridine nucleotides. As such, we have studied the kinetics of accumulation and metabolism of endogenous ATP in the extracellular medium of several different cell types. Our results illustrate for the first time a "constitutive" release of nucleotide that balances nucleotide hydrolysis and accounts for resting levels of extracellular nucleotides. We establish that the exchange of the ␥-phosphate between adenine and uridine nucleotides at steady state markedly exceeds the ecto-ATPase activity. Moreover, our results highlight the importance of a nucleotide pyrophosphatase activity and reveal that this activity approaches or exceeds that of the ecto-ATPase.
MATERIALS AND METHODS
Cell Culture and Incubations-C6 rat glioma, 1321N1 human astrocytoma, and 16HBE14o
Ϫ human bronchial epithelial cells were grown in Dulbecco's modified Eagle's medium-H containing 5% fetal bovine serum and antibiotics as described previously (23) . ECV-304 human bladder epithelial cells (27) were grown in Medium 199 and 10% fetal bovine serum. All cultures were grown to confluence on 24-well plastic plates (Costar). Prior to assays, the cultures were washed three times and incubated in 0.5 ml of serum-and phenol red-free minimum essential medium (MEM). 2 Luciferin-Luciferase Assay-Samples of extracellular medium were collected and boiled for 1 min, and the luciferin-luciferase assay was performed using a LB953 AutoLumat luminometer (Berthold GmbH), as described previously (21) . Standard curves were performed routinely using molecular biology grade ATP, which was diluted in the same buffer and processed (e.g. boiled) in parallel to cell samples. No loss of ATP was observed during sample boiling. The threshold value for ATP detection was 100 pM (5 fmol/sample), and luminescence was linear with ATP concentration to 1000 nM. 32 P]ATP (specific activity Ͼ3000 Ci/mmol) in the presence of 0.1 units/ml bovine liver nucleoside diphosphokinase (NDPK) and 100 nM UDP or GDP, respectively, for 5 min at 30°C (28) .
Quantification of Nucleotides by HPLC-Except where indicated otherwise, species were separated by HPLC (Shimadzu) via a Dynamax C18 column (Varian) as described previously (21 (Fig. 7F) , an anion exchange system with a 3021C4.6 ion chromatography column (Vydac, Hesperia, CA) was used, and the mobile phase (2 ml/min) developed in 25 mM NaH 2 PO 4 , pH 2.8 (solvent A), for 2 min followed by a linear gradient to 125 mM NH 2 PO 4 , pH 2.9 (solvent B), from 2 to 10 min. 100% solvent B was maintained from 10 to 30 min. The elution times for GTP, ATP, and UTP were 24.7, 20.3, and 16.8 min, respectively. Absorbance at ϭ 260 nm was monitored on-line with an SPD-10A UV detector (Shimadzu, Japan), and radioactivity was measured on-line with a 500TR Radiomatic analyzer (Packard, Australia), as described previously (24) . Full recovery of injected 32 P counts was routinely verified during HPLC runs.
Reagents-ATP, UTP, GTP, and CTP were purchased from Amersham Pharmacia Biotech (Uppsala, Sweden). UDP, ADP, GDP, CDP, 3Ј,5Ј-cyclic AMP, and AMPPNP were from Roche Molecular Biochemicals. AMPPCP and ␣,␤-metATP were from RBI (Natick, MA). Bovine liver UDP-glucose pyrophosphorylase, yeast inorganic pyrophosphatase, Crotalus adamateus nucleotide pyrophosphatase, yeast nucleoside diphosphokinase, firefly luciferase, luciferin, Ap 4 A, Ap 5 A, ADPglucose, ADP-ribose, and AMPPCP were obtained from Sigma.
[␥- 
RESULTS

Extracellular Accumulation of ATP-
The kinetics of extracellular accumulation of endogenous ATP and its metabolism were examined with 16HBE14o Ϫ human bronchial epithelial cells, ECV-304 human bladder epithelial cells, C6 rat glioma cells, and 1321N1 human astrocytoma cells. The growth medium bathing confluent cultures was replaced with 0.5 ml of MEM, and extracellular ATP levels were measured by the luciferin-luciferase assay over a 12-h interval. Consistent with ATP release secondary to mechanical stimulation of the cells (21, (23) (24) (25) , relatively large concentrations of ATP were detected immediately after a change of medium, and these levels decreased steadily with t1 ⁄2 values ϳ30 -40 min ( Fig. 1 and Table I ). Extracellular levels of ATP did not fall to zero but attained a base line in the low nanomolar range within 3 h and remained unchanged for up to 12 h ( Fig. 1 and Table I ).
The dependence of the ATP concentration at base line on both the volume of the extracellular medium and the magnitude of the initial concentration of ATP was determined. The concentration of ATP 1 min subsequent to a wash was 132 Ϯ 19 nM (n ϭ 6) for ECV-304 cells incubated in 0.5 ml of bathing solution. Addition of 1 ml of mineral oil to the post-wash aqueous medium of these cells resulted in a slight increase of the ATP concentration within 1 min (152 Ϯ 25 nM, n ϭ 6), possibly reflecting additional ATP release due to the higher hydrostatic pressure and/or medium stirring. Addition of 1 ml of aqueous medium instead of mineral oil (i.e. the final volume of aqueous medium was 1.5 ml) resulted in a decrease in ATP concentration to 46 Ϯ 7 nM (measured at 1 min, n ϭ 6), consistent with the 1:3 dilution of the initial solution. ATP concentrations further decayed to base-line levels that were similar in nondiluted (0.5 ml of medium: 3.2 Ϯ 1 nM, n ϭ 6) and 1:3 diluted samples (1.5 ml of medium: 2.6 Ϯ 0.4 nM, n ϭ 6). In the four cell lines, addition of exogenous ATP (30 and 300 nM) to resting cells incubated in 0.5 ml of MEM resulted with time in baseline ATP concentrations that were indistinguishable from baseline values of control cells (shown in Table I ). The t1 ⁄2 values for hydrolysis of exogenous ATP (data not shown) at both 30 and 300 nM were identical to the t1 ⁄2 values for endogenous ATP shown in Table I . These results indicate that extracellular ATP concentrations attain a constant value that is independent of 32 P]ATP then was added at high specific radioactivity, and both the ATP concentration and [␥-
32 P]ATP were quantified by the luciferin-luciferase assay and HPLC analysis, respectively. Although levels of ATP mass remained unchanged, [␥-32 P]ATP was near completely metabolized within 120 min (Fig. 2) . Thus, the development of a base-line ATP concentration reflects a steady state where hydrolysis is balanced by basal ("constitutive") release of ATP. Consequently, resting cells release ATP at a rate that can be quantitatively deduced from the rate of ATP hydrolysis at steady state.
The simplest approach to determine the rate of ATP release at steady state would be to measure directly the initial rate of [␥- 32 (Fig. 4 ). The 32 P-8 species accumulated more slowly but steadily in the medium of 16HBE14o Ϫ cells, ECV-304 cells, and 1321N1 cells. Accumulation of 32 P-8 was greater than accumulation of 32 P i in the medium of C6 rat glioma cells (Figs. 3 and 4) .
The metabolism of [␥-32 P]ATP in the medium bathing C6 cells was compared with that observed with conditioned medium obtained from these cells (Fig. 5) . The formation of 32 P-8 and 32 P i was dependent on the presence of cells. In contrast, the 32 P-18 species was generated by adding [␥- 32 P]ATP to the cellfree conditioned medium (Fig. 5) . Similar results were observed with ECV-304 and 16HBE14o
Ϫ cells (data not shown). The 32 P-18 species, which co-eluted with authentic standards of GTP and UTP (Fig. 6A) Fig. 7D) . Thus, the endogenous transphosphorylat- ing activity that promotes formation of the 32 P-18 species in the cell-bathing medium could be substituted by exogenous NDPK added to the deproteinized solutions. Third, the 32 P-18 species that co-elute as UTP and GTP on the C18 column (Fig. 7E) were resolved as [ 32 P]UTP (ϳ45%) and [ 32 P]GTP (55%), respectively, by an ion chromatography column (Fig. 7F) .
These findings indicate that endogenous GDP and UDP accumulate in the extracellular medium and serve as acceptor substrates of NDPK. This notion also applies for ADP, as is shown below.
Nucleotide Pyrophosphatase-The 32 P-8 species was purified from C6 cell medium by HPLC (Fig. 8, A and B) and positively identified as 32 PP i by incubating the purified fraction with 2 units/ml UDP-glucose pyrophosphorylase and a molar excess of UDP-glucose. Consistent with the reaction: PP i ϩ UDP-glucose 3 UTP ϩ glucose-1P (23), full conversion of the 32 P-8 species into [ 32 P]UTP was achieved under these conditions (Fig. 8C ). Since different ratios of extracellular 32 PP i versus 32 P i were observed with the different cell types studied, the possibility that an extracellular inorganic pyrophosphatase activity was differentially expressed in a cell-specific manner was examined. C6, 16HBE14o
Ϫ , and ECV-304 cells were incubated in the presence of 32 PP i , and the resulting species accumulating in the medium were analyzed by HPLC. Surprisingly, 32 PP i remained unchanged for up to 120 min after its addition (Fig. 8) , indicating that inorganic pyrophosphatase is not expressed on the surface of these cells. These results suggest that the relative ratio of accumulation of PP i over P i is determined exclusively by the relative activities of E-NPP versus ecto-ATPase. 32 PP i also was the major end product of [␥ -32 P]UTP on C6 cells (Fig. 9) . Interestingly, the terminal phosphate of UTP was transiently (although not completely) transferred to ATP (Fig.  9) , consistent with phosphorylation of endogenous ADP by endogenous NDPK. Since formation of 32 PP i further proceeded after 20 min while [ 32 P]ATP was no longer detected ( Fig. 9) , we conclude that UTP is itself an efficient substrate for the formation of pyrophosphate.
Ecto-nucleotide pyrophosphatases hydrolyze dinucleoside polyphosphates and nucleotide sugars, but also generate free pyrophosphate (and AMP) from ATP (26) . Therefore, these enzymes are logical candidates for the ATP pyrophosphatase activity described in this study. Although we have not measured the direct conversion of ATP to AMP as proof of principle for E-NPP activity, conversion of [␥-32 P]ATP to 32 PP i was effectively prevented by the E-NPP inhibitor ␣,␤-metATP (Fig.  10) and was delayed by Ap 4 A, Ap 5 A, UDP-glucose, ADP-glucose, ADP-ribose, AMPPCP, and AMPPNP (Fig. 10) , all of which are known substrates of the E-NPP family.
The kinetic constants for the ATP-dependent accumulation of 32 PP i and 32 P i on C6 cells were calculated (Table II) . Although V max values for PP i formation were about one half of those for P i , the PP i -generating activity exhibited a K m(app) for ATP that was approximately 6 times lower than the K m(app) of the ecto-ATPase activity. Thus, at steady state where [ATP] Ͻ Ͻ K m , the formation of PP i on C6 cells exceeds by a factor of 3 that of P i (determined by the V max /K m ratios) suggesting that E-PPN activity is the major regulator of the extracellular levels of nucleotides that are released by resting cells. This conclusion also is consistent with the results described earlier (Fig. 3) , which illustrated that accumulation of 32 PP i at steady state on resting C6 cells was 3-4 times higher than accumulation of 32 P i . The V max /K m values for the overall ATP hydrolysis reaction on C6 cells (ϳ0.03 min Ϫ1 ; Table II) closely approached the first order rate constant value (k ϭ 0.02 min
Ϫ1
) calculated from the t1 ⁄2 values, as detailed in Fig. 1 and Table I . DISCUSSION In the present study, we demonstrated that basal (or "constitutive") release of ATP is a characteristic of resting cells, and we have defined conditions that allow quantification of the basal rate of ATP release. Both mechanically released ATP and exogenous ATP decay to a steady state where the magnitude of nucleotide hydrolysis and basal release are balanced. At steady state, extracellular ATP concentrations are independent of both the volume of the extracellular solution and the initial ATP input. Thus, ATP concentrations in the extracellular medium of resting cells are an intrinsic attribute of the tissue and reflect a balance between the capacity of the cells to release ATP "constitutively," and the efficiency of the ATP-hydrolyzing ecto-enzymes.
The basal rate of ATP release was determined based on bulk ATP concentrations. However, ATP concentrations measured in the entire medium are unlikely to accurately reflect the concentration at the cell surface. ATP and UTP levels observed in the medium bathing resting 1321N1 cells (Table I and Refs. 23 and 25) are below threshold values for stimulation of P2Y receptors (24, 25) . However, addition of apyrase or hexokinase to resting P2Y 2 or P2Y 4 receptor-expressing 1321N1 cells resulted in significant reduction of the basal accumulation of inositol phosphates (21, 24, 25) , suggesting that local nucleotide concentrations were high enough to confer basal activity to these receptors. These results indicate that quantification of ATP and UTP in the bulk medium likely reflects a fraction of the actual nucleotide mass that accumulates transiently in the vicinity of the P2Y receptors. Consistent with this notion, using an in situ assay for ATP whereby cell surface-bound luciferase acts as a bioluminescent sensor for ATP, Dubyak and colleagues (30) recently reported that ATP concentrations in the bulk medium of thrombin-stimulated platelets underestimate by at least 1 order of magnitude the ATP concentration near the cell surface. "Constitutive" release of ATP may be physiologically relevant particularly in tissues such as human airways, which are covered by a thin layer (ϳ1 l/cm (Ref. 2)) of surface liquid (31) . The P2Y 2 receptor of airways controls several components of mucociliary clearance by promoting Ca 2ϩ -dependent Cl Ϫ secretion, mucin secretion, and ciliary beating (31) (32) (33) (34) (35) . Based on the observed rate of ATP release from resting 16HBE14o Ϫ cells (Table I) , accumulation of ATP in the periciliar airway surface liquid would proceed at a rate of ϳ20 nM/min, and ATP accumulation would rapidly exceed EC 50 values for P2Y 2 receptor activation if substantial metabolism of nucleotide did not occur.
We speculate that basal release of ATP provides a mechanism of activation of the P2Y 2 receptor that controls physiological functions in "resting" airways.
We reported recently that nucleotide release by mechanically stimulated cells, which represented 0.5-10% of the intracellular pool (21, (23) (24) (25) , was not associated with cell damage (assayed by LDH activity, 51 Cr release, or with the fluorescent probe calcein (21, 23-25) ). Resting cells release one millionth of the total cellular ATP (23) sensitivity of available assays for cell lysis. Thus, our data do not rule out the possibility that ongoing irreversible membrane damage of a very small number of cells may contribute to the observed rates of ATP release. However, increasing evidence suggests that release of cytosolic ATP is a cell-regulated process (4, 16, 22, 36, 37) , which may involve the action of glibenclamide-sensitive K ϩ channels (16), 5-nitro-2-(3phenylpro-pylamino)benzoic acid-sensitive Cl Ϫ channels (22, 37) , and/or phosphatidylinositol 1,4,5-trisphosphate kinase (36) . It has been speculated that ATP release occurs via members of the ABC transporter family of proteins such as the cystic fibrosis transmembrane regulator (38, 39) , but this notion was not sustained by a number of studies including experiments with cystic fibrosis transmembrane regulator-deficient cells in experiments where cystic fibrosis transmembrane regulator was overexpressed in cells where the P2Y 2 receptor acted as a biosensor for ATP/UTP release (22, 27, 37, 40) . Although the mechanism whereby non-excitatory cells release nucleotides remains unclear, basal ATP release occurs at negligible rates compared with cellular ATP turnover and, thus, may provide a "purinergic tone" to non-excitatory tissues without compromising the energetic balance of the cells.
The present study also illustrates the complexity of the cellular pathways involved in the regulation of extracellular nucleotide levels. Our results indicate that an extracellular NDPK activity is responsible for the continuous and reversible interchange of ␥-phosphate within endogenous nucleotides. This NDPK activity is so large that transfer of [␥-32 P]phosphate from ATP to both GTP and UTP was detected in all cell types prior to measurable accumulation of 32 PP i or 32 P i . These data are consistent with our previous kinetic analysis of NDPK and nucleotidase activities on 1321N1 cells (29) , which indicated that NDPK activity exceeded by a factor of 20 that of the ecto-nucleotidase (29) . To our knowledge, this is the first observation of ecto-NDPK activity that plays an active role in the forward and reverse transfer of the terminal phosphate of endogenous ATP to other endogenous nucleotides, e.g. UDP.
Our results are not only consistent with our previous observation of extracellular accumulation of UTP (22, 25) but also indicate that UDP, ADP, and GDP accumulate in amounts comparable to those of triphosphonucleotides. Recently, we have observed that ADP concentrations in the medium of resting C6, 16HBE14o
Ϫ , ECV-304, and 1321N1 cells were at least 5 times higher than ATP concentrations at steady state (41) . Although the present study cannot rule out the possibility that ADP and other nucleoside diphosphates are co-released with NTPs, our previous observations with [ (Figs. 3 and 4) . The NDPK activity not only establishes a constant ratio between the triphosphate nucleotide signaling molecules, but also provides an extracellular ATP regenerating system under conditions where the high energy phosphate bond of ATP is selectively consumed, e.g. during phosphorylation of extracellular proteins (4) .
Our data indicate two extracellular pathways for ATP hydrolysis at steady state. Accumulation of orthophosphate along with the higher levels of extracellular nucleoside diphosphates relative to triphosphates (as discussed above) suggests an ectonucleotidase activity with preference for NTPs over NDPs, i.e. CD39-L1. However, 32 PP i is the major end product of [␥-
32 P]ATP hydrolysis in C6 cells, and it accumulates significantly on ECV-304, 16HBE14o
Ϫ , and 1321N1 cells. Since the observed K m value for PP i formation on C6 cells was ϳ6 times smaller than K m values for P i formation (Table II) , we speculate that the PP i -generating activity (likely E-NPP) might be important for controlling the net NTP concentrations while the CD39-L1 activity determines the relative amounts of NTP versus NDP at steady state. A recent study suggested that PC-1 hydrolyzes ATP on C6 cells (42) . Whether this E-PPN is responsible for the ATP/UTP pyrophosphatase activity described in the present study and whether additional mechanisms are involved in the formation of PPi remain to be determined.
The biological significance of extracellular ATP and UTP has been supported in recent years by direct demonstration of their release and by pharmacological studies of P2 receptors that are potently stimulated by these nucleotides. However, a subset of the cloned P2Y receptors, i.e. P2Y 1 and P2Y 6 receptors, and a yet to be cloned G i /adenylyl cyclase-coupled P2Y receptor are specifically activated by nucleoside diphosphates. The concerted action of ecto-ATPases, which convert NTP to NDP, and ecto-NTP pyrophosphatases, which hydrolyze NTP to AMP bypassing the formation of NDP, offers a control mechanism for the autocrine activation of P2Y 1 and P2Y 6 receptors. Our data support the idea that nucleotide release, accumulation, and interconversion are integrated components of resting cells. 
